Car Therapy Program News Today

Sikander Ailawadhi, MD, discusses non-BCMA CAR T-cell therapies currently under investigation in multiple myeloma.

Sikander Ailawadhi, MD, discusses key considerations for the potential sequencing of bispecific antibodies and other BCMA-directed therapies in multiple myeloma.

Sikander Ailawadhi, MD, oncologist, Department of Hematology, CAR T-Cell Therapy Program, Mayo Clinic, discusses how the investigational agent iopofosine I-131 may address unmet needs for patients with Waldenström macroglobulinemia.

Cancer. It’s the word no patient wants to hear—but the weapons to fight it are being created right here by the world’s finest physicians.